Why tirzepatide ordering is a protocol-economics problem
Tirzepatide programs run across a wide titration range, and the landed cost per vial can change as the patient escalates. That makes the ordering question economic rather than purely operational: to price a protocol you need the per-vial 503A cost at each step, not a single blended rate or a post-placement invoice. Wells Pharmacy Network compounds tirzepatide in its own facilities and delivers it through WellsPx3. Per-Rx pricing is available inside WellsPx3 order management after an order is placed, and Wells does not publish per-vial tirzepatide rates on wellsrx.com. Confirm the per-step economics directly in a WellsPx3 demo rather than assuming a flat catalog price.
This page covers ordering workflow and economics, not clinical dosing. The titration schedule is a prescriber decision; the platform's job is to surface what each step costs before you pay and to route the right vial to the right patient. What to evaluate: can you see per-step cost before checkout, can you batch the full refill day, and are step-vial mismatches caught before payment?